You Position: Home > Paper
低剂量CT筛查肺癌功不可没
( views:465, downloads:688 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 4
- DOI:
- 10.3760/cma.j.issn.1001-0939.2017.04.001
- Key Word:
- No keyword available
Abstract： 本刊在2015年第4期刊登了一篇署名张国桢与白春学[1]的专题笔谈:"胸部低剂量CT筛查肺癌的是与非",该文十分精辟地论证了胸部低剂量CT筛查肺癌(简称CT筛查)的利与弊,在引证大量无可辩驳事实的基础上,对该方法作出了充分的肯定.本来有关争议已经可以平息,但近来该方案在国内又面临前所未有的巨大挑战,甚至有被彻底颠覆的危险.之所以这样,皆因提出异议的专家级别太高、过于权威.
- [1]张国桢,白春学.胸部低剂量CT筛查肺癌的是与非[J].2015,(4).
- [2]Pasmantier MW,Libby DM,Yankelevitz DF,etc.Survival of patients with stage I lung cancer detected on CT screening.[J].2006,355(17).
- [3]Infante, Maurizio,Cavuto, Silvio,Lutman, Fabio Romano,etc.Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography[J].2015,191(10).
- [4]Ali, Muhammad Usman,Miller, John,Peirson, Leslea,etc.Screening for lung cancer: A systematic review and meta-analysis[J].2016,89.
- [5]Aberle DR,Adams AM,Berg CD,etc.Reduced lung-cancer mortality with low-dose computed tomographic screening.[J].2011,365(5).
- [6]Wille, Mathilde M. W.,Dirksen, Asger,Ashraf, Haseem,etc.Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling[J].2016,193(5).